FlhB Loop Targeting for Bacterial Toxin Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack structural information on the cytoplasmic domain of FlhB from the flagellar secretion system, hindering the development of compounds that inhibit toxin secretion by virulent bacteria using the needle type III secretion system.
Innovation Solution
The method involves screening compounds that interact with the C-terminal cytoplasmic domain of FlhB, specifically targeting the flexible loop region to reduce its flexibility, thereby inhibiting toxin secretion by virulent bacteria such as Salmonella typhimurium and other pathogenic species.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If structural information on the cytoplasmic domain of FlhB is obtained, then compound screening for inhibiting toxin secretion becomes feasible, but the complexity of obtaining structural information increases
Solution Approach 1:
The patent uses homology modeling to create a computational copy of the FlhB cytoplasmic domain structure based on known homologous structures. This virtual model enables compound screening without requiring actual experimental determination of the protein structure, thus obtaining reliable structural information while avoiding the complex and time-consuming experimental procedures.
2Reliability
If the loop region flexibility is reduced to inhibit toxin secretion, then the secretion inhibition efficacy improves, but the structural stability of FlhB may be compromised
Solution Approach 1:
The patent applies compound binding specifically to the loop region of the FlhB cytoplasmic domain, creating a localized effect that reduces flexibility only where needed for secretion inhibition. The rest of the FlhB structure maintains its native stability, achieving selective functional inhibition without global structural compromise.
3Adaptability or versatility
If compounds targeting the FlhB loop region are screened, then novel anti-bacterial drugs can be identified, but the screening complexity and time required increase
Solution Approach 1:
The patent replaces traditional high-throughput experimental screening methods with computational docking simulations. This substitution allows virtual screening of compounds against the FlhB loop region, dramatically reducing the time and resource requirements while maintaining the ability to identify novel anti-bacterial drug candidates.
Data Source
AI summary
The present invention relates to a method for screening a compound that inhibits secretion of toxins into host-cell cytoplasm by virulent bacteria using a needle type III secretion system. The compound of the invention is selected by screening for a compound which interacts with a loop region of the cytoplasmic domain of the membrane protein FlhB from Salmonella typhimurium or a paralog thereof. Compositions including the compound of the invention, use of the compound, and methods of treating disorders caused by virulent bacteria are also provided.